Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deals and Financings

Set Alert for Deals

AAOS 2019: OSSO VR Develops VR Training Tool For Smith & Nephew's NAVIO Robot, And More On Orthorobotics

Osso VR partnered with Smith & Nephew to develop a VR training tool that will be showcased at this year's American Association of Orthopedic Surgeons' (AAOS) conference, taking place in Las Vegas from March 12-16. Orthopedic robotic systems continue to draw high interest from surgeons. The recent US FDA clearance of Zimmer Biomet's ROSA total knee replacement system will add competition to the current market dominated by Stryker's MAKO and Smith & Nephew's NAVIO.

Commercial Deals Orthopedics
Advertisement

Latest From Deals

Medtech Money Flow: M&A & VC Deals, March 4-10, 2019 – ResMed Reels In Korean Respiratory Biz

In this week's edition of Medtech Money Flow, ResMed inks a $220M deal to buy Korean respiratory device maker HB Healthcare.

M & A Deals

Pacts In Medtech: Circassia, AIT Team Up To Treat Hypertension In Newborns; Otsuka, Click Collaborate On Depression App

Derived from Strategic Transactions, Informa's premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech feature highlights notable technology alliances, R&D partnerships and commercial collaborations. This edition covers industry pacts that were sealed in January and February 2019.

Pacts in Medtech Deals

Medtech Money Flow: M&A And VC Deals, Feb. 11-17, 2019

This edition of Medtech Money Flow rounds up the M&A and venture financing deals, as recorded in our M&A and VC Deal Trackers, from Feb. 11 - 17, 2019.

M & A Deals

QUOTED. Feb. 15, 2019. Larry Biegelsen.

Johnson & Johnson announced it will acquire robotic startup Auris Health for $3.4bn in cash, plus up to $2.4bn in milestones. See what Wells Fargo analyst Larry Biegelsen wrote about it here.

Quoted Deals

Johnson & Johnson Diversifies Robotic Efforts With Auris Health Aquisition

Johnson & Johnson will acquire robotic startup Auris Health for $3.4bn in cash, plus milestones payments of up to $2.4bn. Auris developed the FDA-cleared Monarch platform, which is expected to rival Intuitive Surgical's robotic-assisted bronchoscope device, Ion, awaiting FDA clearance.

Deals Surgery

Device Week, Feb. 13, 2019 –  Femtech Draws Investment; Smith & Nephew/Nuvasive Merger Rumors Emerge

In this edition of Device Week, Medtech Insight’s Reed Miller talks to managing editor Marion Webb about the growing interest among investors in "femtech," technology that specifically addresses women's health issues that have been frequently overlooked in the past. And London-based reporter Catherine Longworth addresses the recent media reports that Smith & Nephew may make a bid for spine-device company Nuvasive.

Device Week Business Strategies

Edwards Lifesciences Buys CAS For $100M

Edwards Lifesciences has made its first acquisition since 2017, inking a $100m deal to buy monitoring technology company CAS Medical Systems.

M & A Deals

Medtech Money Flow: M&A And VC Deals, Jan. 28-Feb. 10

This edition of Medtech Money Flow rounds up the M&A and venture financing deals, as recorded in our M&A and VC Deal Trackers, from Jan. 28 - Feb. 10, 2019.
M & A Deals

Livongo Buys Behavioral Health Firm In Multimillion Dollar Deal, Plans To Hire 300-500 People

Livongo, which developed a digital platform for managing chronic conditions, announced Jan. 30 it acquired myStrength, a Denver-based digital behavioral health company. The company didn’t disclose financial details, but Livongo's executive chairman Glen Tullman told Medtech Insight the acquisition cost was in the "tens of millions of dollars."

Commercial Digital Health
See All
UsernamePublicRestriction

Register